Kate E Lines Selected Research

Kate E Lines Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2015
5	Multiple Endocrine Neoplasia Type 1 01/2022 - 01/2015
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2016
2	Primary Hyperparathyroidism 12/2023 - 01/2022
2	Primitive Neuroectodermal Tumors (PNET) 01/2023 - 01/2018
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2023 - 01/2016
2	Prolactinoma (Prolactinomas) 01/2022 - 01/2019
2	Adenoma (Adenomas) 01/2021 - 09/2019
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2019 - 09/2018
1	Hypercalcemia (Milk Alkali Syndrome) 12/2023
1	Nephrolithiasis 12/2023
1	Renal Insufficiency (Renal Failure) 12/2023
1	Osteoporosis 12/2023
1	Disease Progression 12/2023
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 10/2023
1	Marshall-Smith syndrome 06/2023
1	Bartter Syndrome (Syndrome, Bartter) 07/2022
1	Gitelman Syndrome 07/2022
1	Secondary Hyperparathyroidism 11/2020
1	Hyperparathyroidism 2 11/2020
1	Gout 11/2020
1	Chronic Renal Insufficiency 11/2020
1	Juvenile gout 11/2020
1	Hyperuricemia 11/2020
1	type 1 familial Hypocalciuric hypercalcemia 11/2020
1	Hypocalcemia 01/2020
1	Pituitary ACTH Hypersecretion 09/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Genomic Instability 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Carney Complex 01/2015
1	Familial Isolated Pituitary Adenoma 01/2015
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012
1	Adenocarcinoma 04/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2012
4	Calcium-Sensing ReceptorsIBA 12/2023 - 01/2016
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 01/2016
3	MicroRNAs (MicroRNA)IBA 09/2018 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 06/2023 - 01/2021
2	ChromatinIBA 01/2023 - 01/2021
2	CateninsIBA 01/2021 - 01/2018
2	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 01/2015
2	S100 Proteins (S 100 Protein)IBA 09/2019 - 04/2012
1	Parathyroid Hormone (Parathormone)IBA 12/2023
1	NFI Transcription FactorsIBA 06/2023
1	ChloridesIBA 07/2022
1	PotassiumIBA 07/2022
1	SodiumIBA 07/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	5' Untranslated Regions (5' UTR)IBA 01/2021
1	LuciferasesIBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	AldosteroneIBA 01/2021
1	ChromograninsIBA 11/2020
1	Glucagon (Glukagon)FDA Link 11/2020
1	Cyclin-Dependent Kinase Inhibitor p27IBA 11/2020
1	Uric Acid (Urate)IBA 11/2020
1	MTOR InhibitorsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Hormones (Hormone)IBA 09/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2019
1	Insulin-Like PeptidesIBA 09/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2019
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	Cyclin D1IBA 09/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	pasireotideIBA 01/2016
1	CalciumIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2015
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2015
1	Cathepsin ZIBA 04/2012

Therapy/Procedure

6	Therapeutics 10/2023 - 01/2016
2	Parathyroidectomy 12/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Biological Therapy 01/2018